当前位置:主页 > 医学论文 > 中医论文 >

成骨片调节microRNA在激素性股骨头缺血坏死差异表达的初步研究

发布时间:2018-06-10 15:24

  本文选题:生脉成骨片 + 微小RNA ; 参考:《广州中医药大学》2016年博士论文


【摘要】:目的:1.探讨中药袁氏生脉成骨片治疗激素性股骨头缺血坏死(Steroid-induced Osteonecrosis of Femoral Head SONFH)的临床疗效。2.探索microRNA在SONFH患者外周血中的差异表达,分析差异表达的microRNA可能的调控作用。3.寻找中药干预SONFH兔模型中microRNA的差异表达,分析中药调控microRNA表达治疗SONFH可能的机理。方法:1.观察26例SONFH患者口服袁氏生脉成骨片每日3次,每次6粒,共服3个月,记录并比较SONFH患者服用药物前、服药1个月、服药2个月和服药3个月患侧髋关节Harris评分、VAS评分,收集数据进行统计学分析。评价服用袁氏生脉成骨片对SONFH患者髋关节Harris评分、VAS评分的影响。2.选取2014年7月~2015年2月广州中医药大学第一附属医院关节科门诊就诊的ARCOⅡ期SONFH患者6例(观察组)及同期广州中医药大学在校健康志愿者6例作为对照组。采集两组研究对象血浆,采用microRNA Real-time PCR芯片筛选差异表达的microRNA。根据TargetScan、mirBase及miRanda三个数据库预测差异表达microRNA的靶基因并进行生物信息学分析。3.选取普通级健康成年新西兰兔,体重2.5~3.0kg,雌雄各半,共30只。以随机数字表法分为中药组、对照组和空白组,各10只。中药组和对照组每只每日以内毒素10ug/kg为总量,经耳缘静脉分2次进行注射,共注射2日,于第3次注射内毒素时以甲强龙40mg/kg行臀肌注射,而后每间隔24h以甲强龙40mg/kg注射1次,共注射甲强龙3次。空白组于相同时间点注射等量生理盐水,注射期间各组兔均臀肌注射青霉素4万单位/只,预防感染。中药组于最后一次注射甲强龙时以袁氏生脉成骨片0.4片/kg灌胃,对照组及空白组以相同计量生理盐水灌胃,灌胃8周。于造模4周时,中药组与对照组各随机选取1只兔,取股骨头样品行HE染色,观察造模成功与否。灌胃完成后收集兔血浆采用高通量测序法测定其microNRA相对表达量,筛选出观察组、对照组较空白组差异表达的microRNA,获取此调控途径中的关键microRNA进行生物信息学分析。结果:1.口服袁氏生脉成骨片前、服药1个月、服药2个月、服药3个月患侧髋关节Harris评分分别为38.17±4.02,39.83±3.97、42.67±2.25和44.33±3.20,患侧髋关节VAS评分分别为6.83±0.41、6.33±0.52、5.00±0.89和4.33±0.52,服药前与服药2、3个月相比较均具有统计学差异。2.SONFH患者血浆中采用microRNA Real-time PCR芯片检测752个microRNA,两组差异表达的microRNA18个,其中观察组上调13个,下调5个。共筛选出交集靶基因887个。GO分析显示,观察组较对照组差异表达microRNA调控的靶基因功能主要包括解剖结构形态、间充质细胞增殖、细胞的代谢过程等,Pathway分析显示靶基因明显富集于多条信号通路。3.在SONFH兔模型实验中采用miRDeep2.0进行microRNA预测,共预测出887个可能microRNA。对照组与空白组之间存在差异表达的microRNA,经同源性分析筛选出与之对应的人类microRNA:hsa-miR-941和hsa-miR-187。并且hsa-miR-941和hsa-miR-187表达量在空白组、对照组和中药组间呈现先升高再回落的表达趋势。hsa-miR-187可调控细胞凋亡和血管生成。MAPK信号通路在中药组与空白组差异表达的microRNA靶基因中富集明显。结论:1.袁氏生脉成骨片可有效改善ARCOⅡ期SONFH患者患侧髋关节Harris评分和VAS评分。2.本研究发现SONFH患者血浆中microRNA较正常人出现差异表达,说明这些差异表达的microRNA可能作为筛选SONFH的生物学标志物。3.袁氏生脉成骨片通过影响microRNA的差异表达,调控多条信号通路,抑制细胞凋亡、促进血管生成可能是其治疗SONFH的作用机制。
[Abstract]:Objective: 1. to explore the clinical effect of Yuan's raw vein osteogenesis tablets on hormone induced osteonecrosis of the femoral head (Steroid-induced Osteonecrosis of Femoral Head SONFH).2. explore the differential expression of microRNA in the peripheral blood of patients with SONFH, and analyze the possible regulating role of the differentially expressed microRNA in the microRNA. The differential expression of oRNA was used to analyze the possible mechanism of microRNA expression in the treatment of SONFH. Methods: 1. to observe 26 cases of SONFH patients taking oral Yuan Shisheng vein osteogenesis tablets 3 times a day, 6 capsules each time for 3 months, recording and comparing SONFH patients before taking drugs for 1 months, taking medicine for 2 months and taking medicine 3 months for the side hip joint Harris score and VAS score. Collect data for statistical analysis. Evaluate the effect of Yuen Sheng Mai osteogenesis on the Harris score of the hip joint of SONFH patients and the effect of VAS score on 6 cases of ARCO II SONFH patients in the First Affiliated Hospital of Guangzhou University of Chinese Medicine from July 2014 to February 2015 (observation group) and Guangzhou University of Chinese Medicine at the same time. 6 subjects were selected as the control group. The plasma of two groups of subjects were collected, and the differentially expressed microRNA. was screened by microRNA Real-time PCR chip. The target genes of microRNA were predicted by the three databases of TargetScan, mirBase and miRanda, and the healthy adult New Zealand rabbits were selected by the bioinformatics analysis, and the weight of 2.5 ~ 3.0kg was selected. A total of 30 males and females were divided into two groups. The random number table was divided into Chinese medicine group, control group and blank group, each 10. The total amount of 10ug/kg in the traditional Chinese medicine group and the control group was injected into the ear vein 2 times for 2 days. At the time of third injections of endotoxin, the gluteal muscle was injected with methylprednisolone 40mg/kg, and then each interval 24h was a strong dragon 40mg/. Kg was injected 1 times and a total of 3 times a strong dragon was injected. The blank group injected the same amount of normal saline at the same time point. The rabbits were injected with penicillin 40 thousand units / only to prevent infection during the period of injection. The Chinese medicine group was given 0.4 slices of Yuan's raw vein osteogenesis tablet for the stomach during the last injection of a strong dragon, and the control group and the blank group were given the same measurement of physiological saline. After 8 weeks of gavage, 1 rabbits were randomly selected from the Chinese medicine group and the control group at 4 weeks. HE staining of the femoral head sample was taken to observe whether the model was successful or not. After the gastric perfusion was completed, the relative expression of microNRA was measured by high throughput sequencing in rabbit plasma, and the observation group was selected and the control group was compared with the blank group, which was expressed in microRNA, and the control route was obtained. The key microRNA in the diameter was analyzed by bioinformatics. Results: 1. before oral Yuan Shisheng vein osteogenesis, taking medicine for 1 months and taking medicine for 2 months, the Harris score of the lateral hip joint for 3 months was 38.17 + 4.02,39.83 + 3.97,42.67 + 2.25 and 44.33 + 3.20 respectively. The VAS score of the affected hip joint was 6.83 + 0.41,6.33 + 0.52,5.00 + 0.89 and 4.33 + 0.52, Before taking the medicine, there were statistically significant differences between the 2,3 months and the 2,3 months of the medicine. The plasma of.2.SONFH patients were detected by microRNA Real-time PCR chip to detect 752 microRNA, and the two groups were expressed differently, among which the observation group was up 13 and down 5. A total of 887.GO analysis of the intersection target gene showed that the observation group was more than the control group. The function of target gene regulated by NA mainly included anatomical structure, proliferation of mesenchymal cells and metabolic process of cells. Pathway analysis showed that the target gene was obviously enriched in multiple signal pathways.3. in SONFH rabbit model experiment using miRDeep2.0 for microRNA prediction, and 887 possible microRNA. control groups were predicted to exist between the blank group and the blank group. The differential expression of microRNA, the homologous analysis of the corresponding human microRNA:hsa-miR-941 and hsa-miR-187., and the expression of hsa-miR-941 and hsa-miR-187 in the blank group, the expression trend between the control group and the traditional Chinese medicine group, which first increased and then receded, can regulate the apoptosis and the angiogenic.MAPK signal pathway in the Chinese Medicine. The group was enriched with the microRNA target gene differentially expressed in the blank group. Conclusion: 1. Yuan Shi Sheng Mai osteogenic tablet can effectively improve the Harris score and VAS score of the patient's hip joint in ARCO II SONFH patients. The difference in the expression of microRNA in the plasma of SONFH patients is more than that of the normal people, indicating that the microRNA of these differentially expressed microRNA may be used as a sieve. The biological marker of SONFH.3. Yuan Shi Sheng Mai osteogenesis tablet, by influencing the differential expression of microRNA, regulates multiple signal pathways, inhibits apoptosis and promotes angiogenesis may be its mechanism for the treatment of SONFH.
【学位授予单位】:广州中医药大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R274.9

【相似文献】

相关期刊论文 前10条

1 陈勇;刘巍;;microRNA影响抗肿瘤药物敏感性相关研究进展[J];临床肿瘤学杂志;2009年09期

2 牛晓晓;王秦秦;;microRNA与肺癌[J];中国肺癌杂志;2010年04期

3 刘静;王小中;;慢性粒细胞白血病相关microRNA的研究进展[J];分子诊断与治疗杂志;2010年04期

4 LEE Younghee;LUSSIER Yves A;;Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancer[J];Chinese Science Bulletin;2010年31期

5 唐志强;;The effect of microRNA-21-siRNA-lentivirus on biological behaviors in human hepatic cancer cell line hepG2[J];China Medical Abstracts(Surgery);2012年01期

6 ;PTEN and PDCD4 are Bona Fide Targets of microRNA-21 in Human Cholangiocarcinoma[J];Chinese Medical Sciences Journal;2012年02期

7 林建宇;朱雨捷;王晶;汤溢飞;徐中华;;急性冠状动脉综合征相关microRNA靶向通路及其功能分析[J];苏州大学学报(医学版);2012年04期

8 崔洪亮;张阳德;;microRNA的协同调控网的构建与研究[J];中国现代医学杂志;2012年33期

9 张明杰;徐卓明;朱丽敏;龚霄雷;黄蕊;;先天性心脏病重度肺动脉高压血浆 microRNA 的分析与验证[J];上海医学;2013年12期

10 孟胜喜;胡义扬;冯琴;;microRNA在中医药防治非酒精性脂肪性肝病中的应用[J];中华中医药杂志;2014年03期

相关会议论文 前10条

1 荆清;袁文俊;秦永文;;microRNA的基因调控新功能[A];中国生理学会第五届全国心血管、呼吸和肾脏生理学学术会议论文摘要汇编[C];2005年

2 靳新;骆志刚;王金华;管乃洋;;microRNA靶标研究进展[A];中国遗传学会功能基因组学研讨会论文集[C];2006年

3 ;Comparasion of Inhibitory Effects on Survivin Gene Expression in Prostate Cancer by Vector-based microRNA and siRNA[A];2008年全国生物化学与分子生物学学术大会论文摘要[C];2008年

4 朱丹霞;徐卫;缪扣荣;方成;朱华渊;董华洁;王冬梅;范磊;乔纯;李建勇;;慢性淋巴细胞白血病microRNA异常表达研究[A];第13届全国实验血液学会议论文摘要[C];2011年

5 Yangchao Chen;;Small molecule modulators of microRNA-34a with anti-cancer activities[A];2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集[C];2013年

6 金希;厉有名;;单纯性脂变与非酒精性脂肪性肝炎间差异microRNA表达谱研究[A];2009香港-北京-杭州内科论坛暨2009年浙江省内科学学术年会论文汇编[C];2009年

7 贾新正;卢肖男;聂庆华;张细权;;鸡部分microRNA的同源预测与克隆验证[A];中国动物遗传育种研究进展——第十五次全国动物遗传育种学术讨论会论文集[C];2009年

8 李炯;段德民;郑克孝;;新型非标记高通量microRNA芯片技术[A];第一届全国生物物理化学会议暨生物物理化学发展战略研讨会论文摘要集[C];2010年

9 徐小涛;陆晓;孙婧;束永前;;肺癌侧群细胞microRNA表达谱检测及初步分析[A];2010’全国肿瘤分子标志及应用学术研讨会暨第五届中国中青年肿瘤专家论坛论文汇编[C];2010年

10 王俊峰;李巍;吴小江;阮康成;;大鼠附睾microRNA表达谱的研究[A];第十一次中国生物物理学术大会暨第九届全国会员代表大会摘要集[C];2009年

相关重要报纸文章 前2条

1 陈英云 乔蕤琳;哈医大成功研发国内首例microRNA转基因及敲减小鼠模型[N];黑龙江经济报;2010年

2 记者 陈青;2厘米以下肝癌检出率88%[N];文汇报;2011年

相关博士学位论文 前10条

1 崔洪亮;microRNA的肿瘤表达研究及协同调控网络分析[D];中南大学;2014年

2 马建华;高粱低磷低氮形态生理特征及低氮响应的microRNA研究[D];山西农业大学;2014年

3 李虔桢;microRNA相关基因遗传多态性与冠心病临床关联及预后研究[D];福建医科大学;2015年

4 王耀辉;血清microRNA作为乳腺癌诊断标志物的研究[D];复旦大学;2014年

5 周霁子;环境因素对心脏畸形胎儿影响的表观遣传学机制[D];复旦大学;2013年

6 张丽;microRNA通过调控小胶质细胞炎性反应参与血管性认知障碍发生发展[D];复旦大学;2014年

7 查若鹏;肝癌转移相关microRNA的鉴定及其分子机制研究[D];复旦大学;2013年

8 方砚田;结肠癌干细胞分选、差异microRNA表达谱检测以及miR-449b-CCND1、E2F3通路在结肠癌干细胞自我更新的机制研究[D];复旦大学;2014年

9 辛成齐;椰枣microRNA鉴定及其在果实发育过程中的表达谱研究[D];中国科学院北京基因组研究所;2015年

10 李栋;先天性心脏病血浆microRNA表达谱及与GATA4靶序列单核苷酸多态性的关联研究[D];山东大学;2015年

相关硕士学位论文 前10条

1 高智红;应用多样性增量方法识别人类基因组microRNA前体序列[D];内蒙古大学;2010年

2 王娜娜;microRNA进化关系及编码特性研究[D];内蒙古大学;2007年

3 王玫;小麦microRNA的鉴定与分析[D];南昌大学;2007年

4 秦保东;原发性胆汁性肝硬化microRNA表达谱的检测及其功能研究[D];第二军医大学;2013年

5 吴晓妍;基于纳米复合材料及生物放大技术构建的电化学microRNA传感器的研究[D];西南大学;2015年

6 周景辉;2型糖尿病microRNA表达谱及其信号通路研究[D];华南理工大学;2015年

7 姜溪;血浆microRNA-486、microRNA-499在肺癌中的表达及临床价值的研究[D];河北大学;2015年

8 林杉;营养诱导舍饲绵羊非繁殖季节发情相关microRNA筛选及其靶基因功能验证[D];石河子大学;2015年

9 林妹妹;microRNA-192 和 microRNA-21 在 IBD 患者中的表达情况[D];福建医科大学;2015年

10 徐娇阳;循环microRNA用于低氧性肺动脉高压早期诊断的实验研究[D];石河子大学;2015年



本文编号:2003686

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2003686.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户ff561***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com